| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |